BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 29229300)

  • 1. c-MYC G-quadruplex binding by the RNA polymerase I inhibitor BMH-21 and analogues revealed by a combined NMR and biochemical Approach.
    Musso L; Mazzini S; Rossini A; Castagnoli L; Scaglioni L; Artali R; Di Nicola M; Zunino F; Dallavalle S
    Biochim Biophys Acta Gen Subj; 2018 Mar; 1862(3):615-629. PubMed ID: 29229300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stabilization of c-KIT G-Quadruplex DNA Structures by the RNA Polymerase I Inhibitors BMH-21 and BA-41.
    Mazzini S; Gargallo R; Musso L; De Santis F; Aviñó A; Scaglioni L; Eritja R; Di Nicola M; Zunino F; Amatulli A; Dallavalle S
    Int J Mol Sci; 2019 Oct; 20(19):. PubMed ID: 31590335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In silico identification of novel ligands for G-quadruplex in the c-MYC promoter.
    Kang HJ; Park HJ
    J Comput Aided Mol Des; 2015 Apr; 29(4):339-48. PubMed ID: 25527072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-based design of platinum(II) complexes as c-myc oncogene down-regulators and luminescent probes for G-quadruplex DNA.
    Wang P; Leung CH; Ma DL; Yan SC; Che CM
    Chemistry; 2010 Jun; 16(23):6900-11. PubMed ID: 20437426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-based optimization of FDA-approved drug methylene blue as a c-myc G-quadruplex DNA stabilizer.
    Chan DS; Yang H; Kwan MH; Cheng Z; Lee P; Bai LP; Jiang ZH; Wong CY; Fong WF; Leung CH; Ma DL
    Biochimie; 2011 Jun; 93(6):1055-64. PubMed ID: 21377506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interactions of Pt-ttpy with G-Quadruplexes Originating from Promoter Region of the c-myc Gene Deciphered by NMR and Gel Electrophoresis Analysis.
    Trajkovski M; Morel E; Hamon F; Bombard S; Teulade-Fichou MP; Plavec J
    Chemistry; 2015 May; 21(21):7798-807. PubMed ID: 25847573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quinazoline derivative QPB-15e stabilizes the c-myc promoter G-quadruplex and inhibits tumor growth in vivo.
    Li Z; Liu C; Huang C; Meng X; Zhang L; He J; Li J
    Oncotarget; 2016 Jun; 7(23):34266-76. PubMed ID: 27144522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenanthroline-bis-oxazole ligands for binding and stabilization of G-quadruplexes.
    Medeiros-Silva J; Guédin A; Salgado GF; Mergny JL; Queiroz JA; Cabrita EJ; Cruz C
    Biochim Biophys Acta Gen Subj; 2017 May; 1861(5 Pt B):1281-1292. PubMed ID: 27865994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of cell proliferation by quindoline derivative (SYUIQ-05) through its preferential interaction with c-myc promoter G-quadruplex.
    Ou TM; Lin J; Lu YJ; Hou JQ; Tan JH; Chen SH; Li Z; Li YP; Li D; Gu LQ; Huang ZS
    J Med Chem; 2011 Aug; 54(16):5671-9. PubMed ID: 21774525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nemorubicin and doxorubicin bind the G-quadruplex sequences of the human telomeres and of the c-MYC promoter element Pu22.
    Scaglioni L; Mondelli R; Artali R; Sirtori FR; Mazzini S
    Biochim Biophys Acta; 2016 Jun; 1860(6):1129-38. PubMed ID: 26922833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gaining insights into the small molecule targeting of the G-quadruplex in the c-MYC promoter using NMR and an allele-specific transcriptional assay.
    Kaiser CE; Gokhale V; Yang D; Hurley LH
    Top Curr Chem; 2013; 330():1-21. PubMed ID: 22752577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RNA Polymerase I Inhibition with CX-5461 as a Novel Therapeutic Strategy to Target MYC in Multiple Myeloma.
    Lee HC; Wang H; Baladandayuthapani V; Lin H; He J; Jones RJ; Kuiatse I; Gu D; Wang Z; Ma W; Lim J; O'Brien S; Keats J; Yang J; Davis RE; Orlowski RZ
    Br J Haematol; 2017 Apr; 177(1):80-94. PubMed ID: 28369725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stabilization of G-quadruplex DNA with platinum(II) Schiff base complexes: luminescent probe and down-regulation of c-myc oncogene expression.
    Wu P; Ma DL; Leung CH; Yan SC; Zhu N; Abagyan R; Che CM
    Chemistry; 2009 Dec; 15(47):13008-21. PubMed ID: 19876976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, Synthesis, and Evaluation of Isaindigotone Derivatives To Downregulate c-myc Transcription via Disrupting the Interaction of NM23-H2 with G-Quadruplex.
    Shan C; Yan JW; Wang YQ; Che T; Huang ZL; Chen AC; Yao PF; Tan JH; Li D; Ou TM; Gu LQ; Huang ZS
    J Med Chem; 2017 Feb; 60(4):1292-1308. PubMed ID: 28128954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Dual Inhibition of RNA Pol I Transcription and PIM Kinase as a New Therapeutic Approach to Treat Advanced Prostate Cancer.
    Rebello RJ; Kusnadi E; Cameron DP; Pearson HB; Lesmana A; Devlin JR; Drygin D; Clark AK; Porter L; Pedersen J; Sandhu S; Risbridger GP; Pearson RB; Hannan RD; Furic L
    Clin Cancer Res; 2016 Nov; 22(22):5539-5552. PubMed ID: 27486174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 9-N-Substituted berberine derivatives: stabilization of G-quadruplex DNA and down-regulation of oncogene c-myc.
    Ma Y; Ou TM; Hou JQ; Lu YJ; Tan JH; Gu LQ; Huang ZS
    Bioorg Med Chem; 2008 Aug; 16(16):7582-91. PubMed ID: 18674916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, Synthesis, and Evaluation of New Selective NM23-H2 Binders as c-MYC Transcription Inhibitors via Disruption of the NM23-H2/G-Quadruplex Interaction.
    Wang YQ; Huang ZL; Chen SB; Wang CX; Shan C; Yin QK; Ou TM; Li D; Gu LQ; Tan JH; Huang ZS
    J Med Chem; 2017 Aug; 60(16):6924-6941. PubMed ID: 28714689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effective targeting of RNA polymerase I in treatment-resistant prostate cancer.
    Low JY; Sirajuddin P; Moubarek M; Agarwal S; Rege A; Guner G; Liu H; Yang Z; De Marzo AM; Bieberich C; Laiho M
    Prostate; 2019 Dec; 79(16):1837-1851. PubMed ID: 31524299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A dihydroindolizino indole derivative selectively stabilizes G-quadruplex DNA and down-regulates c-MYC expression in human cancer cells.
    Nagesh N; Raju G; Srinivas R; Ramesh P; Reddy MD; Reddy ChR
    Biochim Biophys Acta; 2015 Jan; 1850(1):129-40. PubMed ID: 25452213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a new class of WNT1 inhibitor: Cancer cells migration, G-quadruplex stabilization and target validation.
    Chang LC; Chen TC; Chen SJ; Chen CL; Lee CC; Wu SH; Yen Y; Huang HS; Lin JJ
    Oncotarget; 2016 Oct; 7(42):67986-68001. PubMed ID: 27626678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.